Optimization of an Automated Ultrasound Cardiac Guidance Tool
1 other identifier
observational
75
1 country
1
Brief Summary
Open-label, single-arm, prospective study. Subjects will undergo one session of 2D Transthoracic Echocardiogram (2D-TTE) ultrasound. The ultrasound will be performed by a trained sonographer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2021
CompletedStudy Start
First participant enrolled
July 22, 2021
CompletedFirst Posted
Study publicly available on registry
July 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 23, 2022
CompletedNovember 14, 2022
July 1, 2022
2 months
July 4, 2021
November 10, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
ACCURACY- Optimization of an automated ultrasound cardiac guidance tool.
To acquire images from different transducer positions, trajectories, and views, at different acoustic windows for capturing images and location relative to body and probe. This study is designed to capture data for the training of the UltraSight Guidance software AI models. The obtained data will not be anlyzed for statistical purposes but will only be used for the algorithm development based on the technician movements recording, with no reference to images quality or medical utilization.
1 year
Eligibility Criteria
Up to 75 cardiac patients will be enrolled in this study.
You may qualify if:
- Age 18 years and above.
- Patients able to understand, read and sign the informed consent
- Patient willing to answer a short questionnaire
You may not qualify if:
- Not willing or not able to sign an inform consent
- Physical limitation to maneuvering the probe on the body
- Unable to lie flat for study
- Patients experiencing a known or suspected acute cardiac event
- Patients with severe chest wall abnormalities
- Patients who have undergone pneumonectomy
- Patients whose anatomy does not lend itself to echocardiography
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UltraSightlead
Study Sites (1)
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Praveen Mehrotra, MD
Thomas Jefferson University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2021
First Posted
July 29, 2021
Study Start
July 22, 2021
Primary Completion
September 20, 2021
Study Completion
September 23, 2022
Last Updated
November 14, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share